Nuzenio

Jazz Pharmaceuticals Bets

Jazz Pharmaceuticals Bets news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 21:36:11 GMTJazz Pharmaceuticals to acquire Actio Biosciences for up to $1.32bn - Eurasia Business News
Mon, 10 Aug 2026 19:01:18 GMT$1.32 Billion for a Molecule: Jazz Pharmaceuticals Bets on Rare-Epilepsy Drug With No Approved Rivals - USA Herald
Mon, 10 Aug 2026 16:17:36 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical Review
Mon, 10 Aug 2026 15:11:12 GMTJazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - Reuters
Mon, 10 Aug 2026 13:45:00 GMTJazz bets on epilepsy again by acquiring Actio for $820M upfront - Endpoints News
Tue, 04 Aug 2026 19:31:56 GMTJazz Pharmaceuticals (NASDAQ:JAZZ) Given New $276.00 Price Target at JPMorgan Chase & Co. - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Jazz Pharmaceuticals Bets.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.